DonCorleone77
Posted - 04/28/24
$ARVN Arvinas price target lowered to $38 from $55 at Citi Citi analyst Yigal Nochomovitz lowered the firm's price target on Arvinas to $38 from $55 and keeps a Neutral rating on the shares. The analyst updated biotechnology models to reflect reported Q4 and 2023 financials.
Quantumup
Posted - 04/22/24
Oppenheimer🏁 $KYMR OP/$53 KYMR has the pot 2 deliver 1st/best-in-indication, Tx's in inflammation/immunology thru the pursuit of validated🎯s/pathways=multi-billion $ oppys if successful. 📝KT-474(IRAK4) P'ship w/ $SNY + $750M cash which believes will take KYMR into 2027: $arvn $pfe
BioRich
Posted - 04/17/24
@WhoIsFrancois @User123321 most definitely. I've taken the approach in my recent purchases $ADXN $MLTX $ARVN $ARRNF and then $VNDA today that my focus is a realistic PT based on management, Financials, timing (e.g., earnings, PRs, Presentations, etc.), price and volume action, and any other intriguing factors such as current, past, and future interactions with FDA.
BioRich
Posted - 04/17/24
$CRMD $ARVN $TRVI and $ARRNF victims of pullback. Still great investments both short-term (weeks/months) and long-term
Thestocktraderhubzee
Posted - 04/15/24
$ARVN HC Wainwright & Co. Maintains Buy on Arvinas, Lowers Price Target to $87
Quantumup
Posted - 04/11/24
Stifel⬆️ $ARVN $72 was $70/Buy~+d $150M cash/shifted '766 rev est2royalty est. Argues, there's a strong case2⬆️'766 sales ests/include milestones under the face that an expanded/accelerated devt plan is likely at $NVS, but stays conservative until further details are disclosed: $pfe
briefingcom
Posted - 04/11/24
$ARVN: Arvinas enters into a transaction with Novartis (NVS), including a global license agreement for the development and commercialization of PROTAC Androgen Receptor Protein Degrader ARV-766 for the treatment of prostate cancer https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240411070822ARVN&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
OpenOutcrier
Posted - 04/11/24
$ARVN (+7.5% pre) Arvinas Inc. (ARVN) Enters License and Asset Agreement with Novartis $NVS - SI https://ooc.bz/l/30070
briefingcom
Posted - 04/11/24
Gapping up: $ELYM +52.4% $ALPN +36.6% $RENT +31.7% $LPCN +7.5% $ARVN +6.1%
DonCorleone77
Posted - 04/11/24
$ARVN $NVS Arvinas enters exclusive strategic license agreement with Novartis for ARV-766 Arvinas (ARVN) announced it has entered into an exclusive strategic license agreement with Novartis (NVS) for the worldwide development and commercialization of ARV-766, Arvinas' second generation PROTAC androgen receptor degrader for patients with prostate cancer. The transaction also includes an asset purchase agreement for the sale of Arvinas' preclinical AR-V7 program to Novartis. Under the terms of the transaction agreements, Novartis will be responsible for worldwide clinical development and commercialization of ARV-766 and will have all research, development, manufacturing, and commercialization rights with respect to the preclinical AR-V7 program. Arvinas will receive an upfront payment in the aggregate amount of $150.0 million. Under the License Agreement, Arvinas is eligible to receive additional development, regulatory, and commercial milestones of up to $1.01 billion....
Stock_Titan
Posted - 04/11/24
$ARVN Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
https://www.stocktitan.net/news/ARVN/arvinas-enters-into-a-transaction-with-novartis-including-a-global-r1zqul5hh08e.html
BioRich
Posted - 04/10/24
$ADXN can we get 30$ today? Shorties have to cover at some point on this rocket ship. Riding that $LUNR capsule to the moon! $ARVN $TERN and $SRPT next
BioRich
Posted - 04/09/24
$ADXN let's slap that 26$ and never look back. DON'T sell. Shorties are screwed and will have to cover. I can see this touching 30$ by EOW if everyone holds their positions. $ARVN and $ARRNF next runners
BenKaitz
Posted - 04/09/24
$ADXN $ARVN this was $300 a share not long ago based on the hope that we would get to the point we are today. In the last two years we have had 0 negative catalysts and dozens of positive catalysts. We’re so undervalued it’s crazy. That’s why people refuse to sell after a 300% run.
BioRich
Posted - 04/09/24
$ARVN started my position yesterday at a premium because In think this can be the next $ADXN. Don't let the share price scare you away. Buy and hold.
StockInvest_us
Posted - 03/28/24
Signal alert: $ARVN - Oversold Trend Short (Undervalued) https://stockinvest.us/l/LlelZD1Ww1
DailyStocksPicks
Posted - 03/22/24
Today's Oversold Stock #2: Summit Therapeutics ($SMMT): Financially, the company faces challenges with a substantial loss against small yearly sales, yet it has seen interest from major investors and shows some promise for long-term investment despite the high risk. The recent sell-off might suggest the stock is oversold, reflecting immediate financial concerns over potential future success. $ARVN, $MLTX, $INDV, $HCM For Detailed https://youtu.be/kiXj5yPn9rc
DailyStocksPicks
Posted - 03/20/24
Today's Oversold Stock #2: Summit Therapeutics ($SMMT): Summit Therapeutics' rollercoaster stock performance raises eyebrows. With a significant sales-to-loss ratio and a towering debt, what could possibly attract big investors like Vanguard and Goldman Sachs? Is the market's reaction justified, or are we missing a piece of the puzzle? Join us as we explore the intricacies of $SMMT's financials and market potential. Don’t miss this eye-opening analysis. $ARVN, $MLTX, $INDV, $HCM For Detailed $SMMT Analysis Watch: https://youtu.be/Rp7HXX5q-1I
LabPsycho
Posted - 03/17/24
$KRON @Digital_Waffle_Pirate Want $KRON to run 500-1000 % like $CCCC or $ARVN? See my idea / potential application of KB-0742 as a proteolysis targeting chimera (PROTAC). Here's the KB-0742 warhead using my Bait-N-Switch Linker bound to CDK9 and E3 Ligase. My proposed application of KRON's KB-0742 has potential to be a 100X Force Multiplier in augmenting specificity for CDK9 in cancer cells and further turbocharges the molecule by bringing catalytic mechanism of action into the mix, hence increased efficacy at a lower dose to help reduce any adverse side effects. At least a hundred hours of thought and effort coupled with my own Artificial Intelligence plus billions of in silico calculations demonstrates proof of concept. My molecular ensemble is ready to use as a template. Do you think KRON will run with this?
theebosshead
Posted - 03/15/24
$COYA $ARVN $VTYX $RCKT all of these have are developing stage 3 trials and price reflects except $CVKD ..this will catch 🔥 when it does
Epawlow8
Posted - 03/12/24
$ARVN Arvinas Inc : BofA Global Research raises price objective to $55 from $50
Stock_Titan
Posted - 03/04/24
$ARVN Arvinas to Participate in Upcoming Investor Conferences
https://www.stocktitan.net/news/ARVN/arvinas-to-participate-in-upcoming-investor-v324adsrlvtb.html
BobBuran
Posted - 2 months ago
Friday This is the second of two posts showing a total of about 50 of my buy stop orders above the market for today. Already bot past ten minutes: $ARVN $NUVL $EBS $stocks
BobBuran
Posted - 2 months ago
Friday This is the first of two posts showing a total of about 50 of my buy stop orders above the market for today. Already bot past ten minutes: $ARVN $NUVL $EBS $stocks
MaverikIT
Posted - 2 months ago
@RonIsWrong @net0trader @Im_not_Mr_Lebowski @Wigglyick @Cash4freedom @IsabellaDC $ARVN
insiderbuyingselling
Posted - 02/27/24
$ARVN new insider selling: 5196 shares. http://insiderbuyingselling.com/?t=ARVN
Estimize
Posted - 02/27/24
$ARVN misses the Estimize EPS Consensus by $1.28 and the Estimize Revenue Consensus by $88.59M. Reports FQ4 earnings of $-2.53 EPS and ...
http://www.estimize.com/arvn/fq4-2023?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits
